C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 2 019.3 INR 1.41% Market Closed
Market Cap: 211.3B INR
Have any thoughts about
Concord Biotech Ltd?
Write Note

Wall Street
Price Targets

CONCORDBIO Price Targets Summary
Concord Biotech Ltd

Wall Street analysts forecast CONCORDBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 2 025.38 INR with a low forecast of 1 737.2 INR and a high forecast of 2 296.35 INR.

Lowest
Price Target
1 737.2 INR
14% Downside
Average
Price Target
2 025.38 INR
0% Upside
Highest
Price Target
2 296.35 INR
14% Upside
Concord Biotech Ltd Competitors:
Price Targets
GLS
Glenmark Life Sciences Ltd
5% Upside
VETO
Vetoquinol SA
27% Upside
DMP
Dermapharm Holding SE
30% Upside
ACB
Aurora Cannabis Inc
56% Upside
000661
Changchun High & New Technology Industries Group Inc
51% Upside
MNMD
Mind Medicine (MindMed) Inc
259% Upside

Revenue
Forecast

Revenue Estimate
Concord Biotech Ltd

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's revenue is 18%. The projected CAGR for the next 3 years is 22%.

18%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Concord Biotech Ltd

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's operating income is 8%. The projected CAGR for the next 3 years is 28%.

8%
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Concord Biotech Ltd

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's net income is 9%. The projected CAGR for the next 3 years is 24%.

9%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CONCORDBIO's stock price target?
Price Target
2 025.38 INR

According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 2 025.38 INR with a low forecast of 1 737.2 INR and a high forecast of 2 296.35 INR.

What is Concord Biotech Ltd's Revenue forecast?
Projected CAGR
22%

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's revenue is 18%. The projected CAGR for the next 3 years is 22%.

What is Concord Biotech Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's operating income is 8%. The projected CAGR for the next 3 years is 28%.

What is Concord Biotech Ltd's Net Income forecast?
Projected CAGR
24%

For the last 3 years the compound annual growth rate for Concord Biotech Ltd's net income is 9%. The projected CAGR for the next 3 years is 24%.

Back to Top